Go back

UK drug regulator consults on conflict-of-interest policy

Image: Lucky Business, via Shutterstock

MHRA sets out plans for public register of interests and advisory panel

Researchers are being invited to have their say on how the UK’s medicines regulator manages conflicts of interest for independent experts.

On 12 April, the Medicines and Healthcare products Regulatory Agency (MHRA) announced a six-week consultation on a number of proposals aimed at strengthening the current code of practice.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.